Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 2;30(7):1582.
doi: 10.3390/molecules30071582.

The Role of Flow Chemistry on the Synthesis of Pyrazoles, Pyrazolines and Pyrazole-Fused Scaffolds

Affiliations
Review

The Role of Flow Chemistry on the Synthesis of Pyrazoles, Pyrazolines and Pyrazole-Fused Scaffolds

Catarina M Correia et al. Molecules. .

Abstract

Nitrogen-containing heterocycles are fundamental scaffolds in organic chemistry, particularly due to their prevalence in pharmaceuticals, agrochemicals and materials science. Among them, five-membered rings, containing two nitrogen atoms in adjacent positions-such as pyrazoles, pyrazolines and indazoles-are especially significant due to their versatile biological activities and structural properties, which led to the search for greener, faster and more efficient methods for their synthesis. Conventional batch synthesis methods, while effective, often face challenges related to reaction efficiency, scalability and safety. Flow chemistry has emerged as a powerful alternative, offering enhanced control over reaction parameters, improved safety profiles and opportunities for scaling up synthesis processes efficiently. This review explores the impact of flow chemistry on the synthesis of these pivotal heterocycles, highlighting its advantages over the conventional batch methods. Although indazoles have a five-membered ring fused with a benzene ring, they will also be considered in this review due to their biological relevance.

Keywords: flow chemistry; green chemistry; indazoles; pyrazoles; pyrazolines; synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structures and numbering of pyrazole 1, dihydropyrazole (pyrazoline) tautomers 24 and pyrazolidine 5.
Figure 2
Figure 2
Chemical structures of indazole 6, pyrazolopyrimidinone 7 and pyrazolopyridine 8 scaffolds.
Scheme 1
Scheme 1
Cyclocondensation of carbonyl compounds 912 with hydrazine derivatives 13.
Scheme 2
Scheme 2
Multicomponent synthesis of pyrazoles.
Scheme 3
Scheme 3
1,3-Dipolar cycloaddition of sydnones with carbonyl compounds.
Scheme 4
Scheme 4
1,3-Dipolar cycloaddition of nitrilimines with terminal alkynes.
Scheme 5
Scheme 5
1,3-Dipolar cycloaddition of diazo compounds with terminal alkynes.
Scheme 6
Scheme 6
Common strategies for the synthesis of N-aryl-1H-indazoles 32.
Figure 3
Figure 3
Principles, advantages and limitations of flow chemistry.
Scheme 7
Scheme 7
Flow synthesis of pyrazole-4-carboxylate derivatives 34.
Scheme 8
Scheme 8
Continuous-flow 1,3-dipolar cycloaddition of alkynes with trimethylsilyldiazomethane to give pyrazoles 36a,b.
Scheme 9
Scheme 9
Synthesis of 3,5-disubstituted pyrazoles 37 under flow conditions.
Scheme 10
Scheme 10
Flow synthesis of pentafluorosulfanylpyrazoles 39 and 39′.
Scheme 11
Scheme 11
Transition metal-free continuous-flow process for the synthesis of 3,5-di- and 1,3,5-trisubstituted pyrazoles 41 and 16, respectively.
Scheme 12
Scheme 12
Photochemical synthesis of pyrazolines 14 and pyrazoles 16 from tetrazoles in flow conditions.
Scheme 13
Scheme 13
Expansion and/or rearrangement and cyclization of pyridinium salts and subsequent carbon deletion for the synthesis of pyrazoles 47, under flow conditions.
Scheme 14
Scheme 14
Continuous-flow synthesis of pyrazole 50 based on the Knorr cyclocondensation.
Scheme 15
Scheme 15
Four-stage multistep setup for continuous-flow production of pyrazoles 53 from anilines.
Scheme 16
Scheme 16
Continuous-flow–microwave hybrid approach for the synthesis of pyrazoles 53.
Scheme 17
Scheme 17
Continuous-flow synthesis of N-aryl-5-methylpyrazole 55.
Scheme 18
Scheme 18
Continuous-flow process for the synthesis of celecoxib 58.
Scheme 19
Scheme 19
Copper-catalyzed cycloaddition of sydnones with terminal alkynes to produce pyrazoles 22 under flow conditions.
Scheme 20
Scheme 20
Synthesis of diazoalkanes in flow followed by cycloaddition in batch conditions to afford pyrazoles 63 and pyrazolines 64.
Scheme 21
Scheme 21
Continuous-flow setup for the in situ generation of diazo compounds and further cycloaddition with alkynes and alkenes to achieve pyrazoles 63 and pyrazolines 64, respectively.
Scheme 22
Scheme 22
Thermal synthesis of N-arylindazoles 66 from nitroaromatic imines via Cadogan reaction, in flow conditions.
Scheme 23
Scheme 23
Cadogan reaction mechanism for the synthesis of N-substituted indazoles.
Scheme 24
Scheme 24
Continuous-flow synthesis of N-arylindazoles 66 by photochemical generation of benzynes and subsequent trapping with sydnones.
Scheme 25
Scheme 25
Three-step-flow procedure for the synthesis of indazole derivatives 66.
Scheme 26
Scheme 26
Synthesis of pyrazolopyrimidinones 72 under flow conditions.
Scheme 27
Scheme 27
Synthesis of pyrazolo[1,5-a]pyridine 74 by thermolysis of azidoacrylates, under flow conditions.
Scheme 28
Scheme 28
Microwave–flow hybrid approach for the synthesis of pyrazolo[3,4-b]pyridin-4-ols 78ac and pyrazolo[3,4-b]pyridin-4-amines 81a,b.

References

    1. Kumar V., Kaur K., Gupta G.K., Sharma A.K. Pyrazole Containing Natural Products: Synthetic Preview and Biological Significance. Eur. J. Med. Chem. 2013;69:735–753. doi: 10.1016/j.ejmech.2013.08.053. - DOI - PubMed
    1. Ebenezer O., Shapi M., Tuszynski J.A. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives. Biomedicines. 2022;10:1124. doi: 10.3390/biomedicines10051124. - DOI - PMC - PubMed
    1. Ahsan M.J., Ali A., Ali A., Thiriveedhi A., Bakht M.A., Yusuf M., Salahuddin, Afzal O., Altamimi A.S.A. Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders. ACS Omega. 2022;7:38207–38245. doi: 10.1021/acsomega.2c05339. - DOI - PMC - PubMed
    1. Puri S., Sawant S., Juvale K. A Comprehensive Review on the Indazole Based Derivatives as Targeted Anticancer Agents. J. Mol. Struct. 2023;1284:135327. doi: 10.1016/j.molstruc.2023.135327. - DOI
    1. Hassani I.A.E., Rouzi K., Assila H., Karrouchi K., Ansar M. Recent Advances in the Synthesis of Pyrazole Derivatives: A Review. Reactions. 2023;4:478–504. doi: 10.3390/reactions4030029. - DOI

LinkOut - more resources